BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 17340017)

  • 1. Skin-homing CD8+ T lymphocytes show preferential growth in vitro and suppress CD4+ T-cell proliferation in patients with early stages of cutaneous T-cell lymphoma.
    Thestrup-Pedersen K; Parhar R; Wu K; Bertilsson PA; Meyer B; Abu-Amero S; Hainau B; Aleisa A; Alfadley A; Hamadah I; Alajlan A; Al-Hussein K; Al-Mohanna F
    Acta Derm Venereol; 2007; 87(2):118-26. PubMed ID: 17340017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
    Nagatani T; Miyazawa M; Matsuzaki T; Iemoto G; Kim ST; Baba N; Miyamoto H; Nakajima H
    Semin Dermatol; 1994 Sep; 13(3):216-22. PubMed ID: 7986691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity.
    Wu Y; Farrell J; Pirmohamed M; Park BK; Naisbitt DJ
    J Allergy Clin Immunol; 2007 Apr; 119(4):973-81. PubMed ID: 17320939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
    Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
    J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation.
    Dummer R; Kohl O; Gillessen J; Kägi M; Burg G
    Arch Dermatol; 1993 Apr; 129(4):433-6. PubMed ID: 8466213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cytotoxic skin-homing CD8+ lymphocytes in cutaneous cytotoxic T-cell lymphoma and pityriasis lichenoides.
    Wenzel J; Gütgemann I; Distelmaier M; Uerlich M; Mikus S; Bieber T; Tüting T
    J Am Acad Dermatol; 2005 Sep; 53(3):422-7. PubMed ID: 16112347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro culture of skin-homing T lymphocytes from inflammatory skin diseases.
    Bang K; Lund M; Mogensen SC; Thestrup-Pedersen K
    Exp Dermatol; 2005 May; 14(5):391-7. PubMed ID: 15854134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cutaneous lymphoma of the Sézary and Bouvrain type. Progress in physiopathologic and therapeutic outlook].
    Bagot M
    Bull Acad Natl Med; 1998; 182(5):927-37; discussion 937-8. PubMed ID: 9735499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
    Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
    Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
    Wu K; Lund M; Bang K; Thestrup-Pedersen K
    Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis.
    Parel Y; Aurrand-Lions M; Scheja A; Dayer JM; Roosnek E; Chizzolini C
    Arthritis Rheum; 2007 Oct; 56(10):3459-67. PubMed ID: 17907151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
    Gormley RH; Hess SD; Anand D; Junkins-Hopkins J; Rook AH; Kim EJ
    J Am Acad Dermatol; 2010 Feb; 62(2):300-7. PubMed ID: 19944484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma.
    Yamanaka K; Clark R; Dowgiert R; Hurwitz D; Shibata M; Rich BE; Hirahara K; Jones DA; Eapen S; Mizutani H; Kupper TS
    Clin Cancer Res; 2006 Jan; 12(2):376-82. PubMed ID: 16428475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset.
    Fozza C; Contini S; Galleu A; Simula MP; Virdis P; Bonfigli S; Longinotti M
    Exp Hematol; 2009 Aug; 37(8):947-55. PubMed ID: 19409953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.
    Takahashi N; Matsumoto K; Saito H; Nanki T; Miyasaka N; Kobata T; Azuma M; Lee SK; Mizutani S; Morio T
    J Immunol; 2009 May; 182(9):5515-27. PubMed ID: 19380800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrins alpha4beta7 and alphaEbeta7 are expressed on epidermotropic T cells in cutaneous T cell lymphoma and spongiotic dermatitis.
    Schechner JS; Edelson RL; McNiff JM; Heald PW; Pober JS
    Lab Invest; 1999 May; 79(5):601-7. PubMed ID: 10334571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
    Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
    Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionally mature CD4 and CD8 TCRalphabeta cells are generated in OP9-DL1 cultures from human CD34+ hematopoietic cells.
    Van Coppernolle S; Verstichel G; Timmermans F; Velghe I; Vermijlen D; De Smedt M; Leclercq G; Plum J; Taghon T; Vandekerckhove B; Kerre T
    J Immunol; 2009 Oct; 183(8):4859-70. PubMed ID: 19801512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.